Business
Jun 02, 2026
June 2 (Reuters) - Shares of Fulcrum Therapeutics (FULC.O), opens new tab plunged 52% on Tuesday after the company said it would abandon development of its…
Jun 02, 2026
CorrectSequence Therapeutics Reports Positive 15-Month Follow-Up Data for CS-206SHANGHAI, June 2, 2026 /PRNewswire/ -- CorrectSequence Therapeutics Co., Ltd. (…
Jun 02, 2026
The drug, pociredir, was being developed as an oral treatment for sickle-cell disease, an inherited blood disorder that can cause pain, anemia, organ damage and…
Jun 02, 2026
CorrectSequence Therapeutics Reports Positive 15-Month Follow-Up Data for CS-206SHANGHAI, June 2, 2026 /PRNewswire/ -- CorrectSequence Therapeutics Co., Ltd. (…
Jun 01, 2026
― Decision follows FDA feedback regarding the implications of the secondary malignancies observed with Tazverik®(tazemetostat) and the product’s subsequent global…
May 20, 2026
Sickle Cell Anemia Testing and Screening Market was valued at USD 494.8 million in 2025 and is expected to reach USD 1,579 million by 2035, growing at a CAGR of 12.…
May 19, 2026
Agios Pharmaceuticals AGIO executives said the company is focused on advancing mitapivat across rare hematologic diseases, highlighting early launch traction in…
May 13, 2026
Agios Pharmaceuticals AGIO announced that it has submitted a supplemental new drug application (sNDA) to the FDA seeking accelerated approval for the label…
May 12, 2026
Our mission is to train the next generation of providers with expertise in the care of individuals with sickle cell disease (SCD) throughout their lifespan.…
May 06, 2026
Casgevy’s approval changed the sickle cell disease landscape. Developed by Vertex Pharmaceuticals and CRISPR Therapeutics, the therapy showed that the…